drugset / Trial / NCT00192777
Concurrent Xeloda and Radiotherapy for Bone Metastases
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Hypothesis: Radiosensitization using Xeloda should improve the rate of complete pain relief. Primary Objective: * To determine the frequency of pain relief for the proposed regimen. Secondary Objective(s): * To determine the duration of pain relief and narcotic relief for the proposed regimen. * To determine the frequency of narcotic relief for the proposed regimen. * To determine the toxicity of concurrent UFT and radiotherapy in patients with bone metastases.
Timeline
- Start
- 2004-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | — |